Elaine Mendonca, Author at Stocks Today

On February 26, 2024, Michael Cherny, an analyst at Leerink Partners, began covering Laboratory Corp (NYSE:LH) with an optimistic outlook,...

Agilitis Stock Soars as THL Partners Acquires Healthcare Technology Firm

Agiliti's stock is on the rise following the news that THL Partners will be acquiring the healthcare technology firm. This...

Oppenheimer Analyst Martin Yang Reaffirms Positive Outlook on Sony Group with Outperform Rating and 108 Price Target

On February 26, 2024, Oppenheimer analyst Martin Yang reiterated his positive outlook on Sony Group (NYSE: SONY), giving it an...

Kerrisdale Capital maintains bearish position on Altimmune ALT

As of February 26, 2024, Kerrisdale Capital has reiterated to Benzinga their position on Altimmune (ALT) – they remain bearish...

Groundbreaking Preclinical Data on TN301 A Potential Breakthrough in Treating HFpEF

Tenaya Therapeutics has recently unveiled groundbreaking preclinical data in Nature Communications on their novel small molecule HDAC6 inhibitor, TN-301, designed...

Owlet Announces 9 Million Private Placement Financing Deal with Series B Preferred Stock

On February 26, 2024, Owlet unveiled a new $9 million private placement financing deal. This will involve the issuance of...

Analyst Initiates Coverage on GoodRx Holdings with Outperform Rating and 8 Price Target

Leerink Partners analyst Michael Cherny has just started covering GoodRx Holdings (NASDAQ: GDRX) with an optimistic Outperform rating and a...

Enlivex Receives Regulatory Approval for Phase 12 Clinical Study on Allocetra for Knee Osteoarthritis

Enlivex has recently obtained regulatory approval from Israel's Health Ministry to kick off a Phase 1/2 clinical study assessing Allocetra...

Maintaining Neutral Rating with Raised Price Target for SM Energy